Dermira, Inc.
Eli Lilly and Company is a global medicine company dedicated to turning science into healing. With nearly 150 years of experience, Lilly focuses on disease areas such as Alzheimer's, cancer, diabetes, and obesity, striving to improve lives through innovative medicines and partnerships. The company emphasizes health, access, and scientific advancement, actively engaging in community support, research, and collaborations to address significant health challenges worldwide.
Industries
Nr. of Employees
medium (51-250)
Dermira, Inc.
Menlo Park, California, United States, North America
Products
PET imaging agents for brain pathology (amyloid and tau)
Regulatory-approved PET tracers used for estimating amyloid plaque density and imaging tau pathology to aid early diagnosis and monitor treatment effects.
PET imaging agents for brain pathology (amyloid and tau)
Regulatory-approved PET tracers used for estimating amyloid plaque density and imaging tau pathology to aid early diagnosis and monitor treatment effects.
Services
Corporate business development and alliance management
Strategic partnering, licensing, M&A evaluation and alliance/innovation management across therapeutic areas.
Early-stage engagement and venture/R&D support (Catalyze360)
Investment, lab facilities and R&D services for early-stage companies, including lab incubation and R&D solutions.
Mobile clinical research unit operations
Community-based screening, trial enrollment and decentralized study operations delivered via mobile research units.
Digital health and telehealth-to-pharmacy service (LillyDirect)
Digital platform connecting patients to telehealth or in-person care with integrated pharmacy fulfillment and self-pay options.
Supplier onboarding and supplier development programs
Prospective supplier registration, supplier resources, mentorship and supplier diversity programs, plus invoicing and payment portals.
Medical information and patient/HCP support services
Medical information call center and online resources for patients and HCPs, including condition and product support and oncology patient financial/benefits assistance.
Corporate business development and alliance management
Strategic partnering, licensing, M&A evaluation and alliance/innovation management across therapeutic areas.
Early-stage engagement and venture/R&D support (Catalyze360)
Investment, lab facilities and R&D services for early-stage companies, including lab incubation and R&D solutions.
Mobile clinical research unit operations
Community-based screening, trial enrollment and decentralized study operations delivered via mobile research units.
Digital health and telehealth-to-pharmacy service (LillyDirect)
Digital platform connecting patients to telehealth or in-person care with integrated pharmacy fulfillment and self-pay options.
Supplier onboarding and supplier development programs
Prospective supplier registration, supplier resources, mentorship and supplier diversity programs, plus invoicing and payment portals.
Medical information and patient/HCP support services
Medical information call center and online resources for patients and HCPs, including condition and product support and oncology patient financial/benefits assistance.
Expertise Areas
- Clinical trial management and decentralised trial operations
- Biologics and gene therapy development
- Radiopharmaceutical and diagnostic development
- Regulatory affairs and safety reporting
Key Technologies
- Positron emission tomography (PET) imaging agents
- Radioligand therapy methods
- AAV-based gene delivery
- Platform-driven oral small-molecule discovery